Loading
GP
Genix Pharmaceutical Corp. Stock: price and insider trades · Canada
Genix Pharmaceutical Corp.: what insiders have been doing
Genix Pharmaceutical Corp. has a thin disclosure history in our data (latest filing: 18 June 2018). New filings will appear here as soon as they are published. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 18 June 2018
Declarations5 total
Common SharesTSXSEDI:3198594
Common SharesTSXSEDI:3196845
Common SharesTSXSEDI:3196029
500,000 shares@ CA$0.02100.0% of flowCommon SharesTSXSEDI:3190960
Common SharesTSXSEDI:3190959
5 of 5 declarations
About Genix Pharmaceutical Corp.
Genix Pharmaceutical Corp. is a Toronto Stock Exchange-listed pharmaceutical company focused on developing innovative treatments. It specializes in the research and commercialization of drugs for various diseases.
